Early detection increases chances to make cancer managable and curable. Theramix's strategy for early detection of cancer targets the tumor microenvironment that tumor growth relies on. We develop imaging techniques to monitor the molecular changes in the altered cellular microenvironment, which make it possible to detect cancer at its onset or when the tumor size is small.
We use our target mapping technology to develop early detection by quantitatively mapping the extracellular molecules that represent the alterations in the microenvironment favorable to tumorigenesis.
